ArticleJournal of oncology2022

Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer.

Meng Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.